Evidence map

ReviewFrontiers in immunology2023

Important denominator between autoimmune comorbidities: a review of class II HLA, autoimmune disease, and the gut.

Meghan A Berryman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

17 papers cite it

2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 37828987